36 results
8-K
EX-1.1
CLDX
Celldex Therapeutics Inc.
17 Jun 20
Celldex Therapeutics Announces Proposed Public Offering of Common Stock
12:00am
or supplier of the Company or any Subsidiary to alter the customer’s or supplier’s level or type of business with the Company or any Subsidiary or (B) a trade
8-K
EX-1.1
CLDX
Celldex Therapeutics Inc.
26 Feb 15
Celldex Therapeutics Prices Public Offering of Common Stock
12:00am
dispute with the employees of the Company, or, to the Company’s knowledge, with the employees of any principal supplier, manufacturer, customer
8-K
EX-1.1
CLDX
Celldex Therapeutics Inc.
5 Dec 13
Celldex Therapeutics Prices Public Offering of Common Stock
12:00am
subsidiaries, or, to the Company’s knowledge, with the employees of any principal supplier, manufacturer, customer or contractor of the Company, exists
8-K
EX-1.1
4kgtvxm28exz oe3
24 Feb 12
Entry into a Material Definitive Agreement
12:00am
8-K
EX-1.1
855jpl9h
18 May 11
Entry into a Material Definitive Agreement
12:00am
8-K
EX-10.1.3
qe1s3ir0zbai lqio
6 Jan 11
Entry into a Material Definitive Agreement
12:00am
424B3
el1 b13u4m3
28 Aug 09
Prospectus supplement
12:00am
425
EX-2.1
5vhkzco fzz
29 May 09
Business combination disclosure
12:00am
8-K
EX-2.1
k4kh t61b
29 May 09
Celldex Therapeutics, Inc. Enhances Precision Targeted Immunotherapy Platform with the Acquisition of CuraGen Corporation
12:00am